Have you heard the latest fantastic news? British Columbia has recently started providing access to lanadelumab (TAKHZYRO) to eligible HAE patients.

For further details and to learn how to access lanadelumab through the province’s Expensive Drugs for Rare Diseases (EDRD) Program, you will need to either speak with your HAE specialist or contact your representative at OnePath, Takeda’s patient support program.

This is certainly welcome and exciting news for HAE patients in British Columbia.